Credit Suisse Ag Citius Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$1.38 - $1.89 $21,781 - $29,831
-15,784 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$1.51 - $2.2 $23,833 - $34,724
15,784 New
15,784 $24,000
Q3 2021

Nov 12, 2021
SELL
$1.74 - $2.6 $240,438 - $359,275
-138,183 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$1.51 - $4.23 $208,656 - $584,514
138,183 New
138,183 $481,000

Others Institutions Holding CTXR

# of Institutions
70
Shares Held
26.7M
Call Options Held
0
Put Options Held
0
View Full List

About Citius Pharmaceuticals, Inc.

CTXR Quotes by TradingView
  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $140M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email